COVID-19: Chinese military researchers test new vaccine in human trials

United States News News

COVID-19: Chinese military researchers test new vaccine in human trials
United States Latest News,United States Headlines
  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 71 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 32%
  • Publisher: 66%

BEIJING: A Chinese military research institute has been approved to test its second experimental coronavirus vaccine in humans, the eighth ...

Small bottles labelled with a 'Vaccine COVID-19' sticker and a medical syringe are seen in this illustration. REUTERS/Dado Ruvic/File PhotoBEIJING: A Chinese military research institute has been approved to test its second experimental coronavirus vaccine in humans, the eighth candidate in clinical trials for China as it emerges as a front-runner in the global fight against COVID-19.

No vaccine has been approved for sale against the virus that has killed over 470,000 people, but more than a dozen candidates have entered different stages of human test globally.The new drug is developed by the Academy of Military Science , a research institute affiliated with the People's Liberation Army, and was approved to proceed to human trial by China's National Medical Products Administration.

AMS' latest candidate, named ARCoV, uses mRNA technology, an approach that is also used for candidates developed by Moderna Inc in the United States and German firm CureVac but has never been tested in China-based clinical trials, the institute said in its social media WeChat late on Wednesday . "The core raw materials and equipment are all domestically produced, and rapid production capacity ramp-up is achievable," Qin Chengfeng, a researcher responsible for the mRNA project, said in the statement.

The Chinese Clinical Trial registry, without naming ARCoV, said a phase 1 clinical trial for an mRNA vaccine, sponsored by AMS, Yunnan Walvax Biotechnology and Suzhou Abogen Biosciences, would start on Thursday and evaluate the safety of the candidate.Separately, Ad5-nCoV, a vaccine candidate co-developed by AMS and CanSino Biologics using a different technique, is under phase-2 clinical trial in China and has won approval to begin human testing in Canada.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ChannelNewsAsia /  🏆 6. in SG

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Covid-19: Beijing market outbreak ‘coming to an end’, health expert saysCovid-19: Beijing market outbreak ‘coming to an end’, health expert says
Read more »

Beijing officials declare COVID-19 outbreak 'under control'Beijing officials declare COVID-19 outbreak 'under control'BEIJING: The new coronavirus outbreak that has infected 256 people in Beijing since early June is 'under control', officials in the Chinese ...
Read more »

Beijing reports 13 new Covid-19 cases vs 9 a day earlierBeijing reports 13 new Covid-19 cases vs 9 a day earlierBEIJING/SHANGHAI (REUTERS) - Beijing's municipal health authority reported on Tuesday (June 23) 13 new cases of the novel coronavirus in the city for June 22, up from nine a day earlier.. Read more at straitstimes.com.
Read more »

China reports 22 new COVID-19 cases, 13 in BeijingChina reports 22 new COVID-19 cases, 13 in BeijingChina reported 22 new coronavirus cases for June 22, 13 of which were in the capital Beijing, the National Health Commission said on Tuesday.
Read more »

Beijing COVID-19 testing to enter 'fast track' as cases mountBeijing COVID-19 testing to enter 'fast track' as cases mountBEIJING: Beijing's mass testing for the new coronavirus will soon enter a 'fast track' as the city's testing capacity expands, a senior municipal ...
Read more »

Chinese firm gets approval to begin human testing for potential COVID-19 vaccineChinese firm gets approval to begin human testing for potential COVID-19 vaccineChina has approved a coronavirus vaccine candidate developed by Chongqing Zhifei Biological Products' unit to begin human testing, the company ...
Read more »



Render Time: 2025-03-03 14:38:35